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Alcohol abuse is the most common cause of end-stage 
liver disease in the United States, but many transplant 
centers are unwilling to accept alcoholic patients be-
cause of their supposed potential for recidivism, poor 
compliance with the required immunosuppression reg-
imen and resulting failure of the allograft. There is also 
concern that alcohol-induced injury in other organs will 
preclude a good result. From July I, 1982, to April 30, 
1988, 73 patients received orthotopic liver transplants 
at the University of Pittsburgh for end-stage alcoholic 
liver disease. Fifty-two (71%) of these were alive at 
25 ± 9 mo (mean ± S.D.) after transplantation, when a 
phone survey of these patients, their wives/husbands, 
and their physicians was performed to evaluate their 
subsequent use of alcohol, current medical condition 
and employment. Data obtained were compared with 
those for nonalcoholic patients selected as transplant 
controls. The recidivism rate has been 11.5%, with most 
patients drinking only socially. Fifty-four percent of the 
survivors are employed, 21% classify themselves as 
homemakers and only 11 (21%) are unable to work. 
Twenty-one patients died after transplantation: the 
most frequent cause of death was sepsis (43%), and in-
traoperative death was the next most common cause 
(28.6%). These data demonstrate that alcoholic patients 
can be transplanted successfully and achieve good 
health not significantly different from that of individ-
uals transplanted for other causes. Thus orthotopic 
liver transplantation is a therapeutic option that should 
be considered for individuals with end-stage alcoholic 
liver disease who desire such therapy. (HEPATOLOGY 
1990;11:159-164.) 
Orthotopic liver transplantation (OLT) is a thera-
peutic option for persons with end-stage liver disease 
that no longer responds to medical treatment (1-3). 
Alcohol-induced cirrhosis and alcoholic hepatitis are 
two of the most common forms of fatal liver disease 
seen in the United States (4). Both conditions can be 
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treated with orthotopic liver transplantation. Because 
alcohol-induced liver injury is the most frequent cause 
of cirrhosis in the United States and other western 
countries, most candidates for OLT are alcoholics (5), 
Few centers, however, have been willing to provide 
transplants to persons with alcohol-induced liver dis-
ease. The major reason for this reluctance has been the 
fear of a high rate of recidivism that might lead to 
disease in the allograft. This opinion persists even 
though little or no data exist concerning the recurrence 
of alcohol abuse after liver transplantation. This study 
was undertaken to provide some data relative to these 
issues. 
MATERIALS AND METHODS 
From July I, 1982. to April 30. 1988, 73 persons with ad-
vanced alcoholic liver disease underwent OLT at the hospital 
of the University of Pittsburgh's School of Medicine. for end-
stage alcoholic liver disease. This is not our entire experience 
to date with alcoholic liver disease; it does, however. include 
an adequate number of patients and duration of time after 
transplant to predict long-term outcome and to make valid 
inferences about the larger entire popUlation (Fig. 1). The 
diagnosis of alcoholic liver disease in each case was based on 
a history of habitual and excessive alcohol consumption in 
the absence of other causes of liver disease. compatible clin-
ical and laboratory findings, pretransplant liver biopsy re-
sults and the results of the examination of the resected dis-
eased liver after transplantation. 
Survivors. their spouses and their local physicians were 
contacted by a protocol phone survey consisting of questions 
regarding current alcohol and illicit drug consumption. 
health status. compliance with the immunosuppression reg-
imen and employment status since transplantation. For the 
purposes of this study. social drinking was defined as the 
consumption of alcohol only on holidays and special occasions. 
moderate drinking was defined as three or fewer drinks per 
week and drinking above this level was defined as excessive. 
The subject's most recent serum transaminase levels were 
obtained from the clinic at the University of Pittsburgh or 
from his/her primary care physician. The control group con· 
sisted of an equal number of age-matched and sex-matched 
control patients transplanted during the same period by the 
same team of physicians and surgeons for end-stage hepa-
tocellular liver disease not resulting from alcohol con-
sumption. 
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FIG. 1. Patients transplanted annually for alcoholic liver disease at the University of Pittsburgh. Note that time period shown exceeds 
the duration of this study. 
TABLE 1. Child's.Pugh clus and mortality of alcoholic 
transplant recipients 
Clu. Total Survived Deeeaeed 
A 2 2 0 
B 24 19 5 
C 47 31 16 
TOTAL 73 52 (71%) 21 (29%) 
Statistical Analysis. Patient survival was calculated by life 
table analysis using the Kaplan·Meier method; the survival 
curves for the two groups of patients were compared by the 
log·rank test. The chi·square test with Yates' adjustment was 
used to test differences between proportions and the signifi· 
cance of associations. A probability value of p < 0.05 was 
considered to be significant. 
RESULTS 
Pretransplant Characteristics. The mean age of the 
alcoholic transplant recipient group at the time of OLT 
was 48.16 ± 8.69 yr (mean ± S.D.), with a range of21 
to 70 yr. Men (79%) predominated in the sample (Fig. 
2). Sixty· four percent of the alcoholic patients trans· 
planted were classified as being in Child's class C, 32% 
were class Band 4% were class A before transplan· 
tation (Table 1), An exact detennination of the period 
of abstinence from alcohol before transplantation was 
impossible to detennine, but most had ceased their al· 
cohol consumption at least 6 rno before transplantation 
(Table 2), Only 7 of the 52 (13%) survivors and 4 (19%) 
in the deceased group admitted to having consumed 
alcohol in the 6 rno before liver transplantation. This 
difference was not statistically significant. 
Survival Analysis. Fifty-two individuals (71%) were 
TABLE 2. Characteristics of alcoholic patients treated 
Duration of alcohoUc ab.tinence 
belore OLT" Survived Deceaeed 
<6 mo (n = 11) 7 4 
6 to 24 mo (n = 29) 25 4 
>24 mo (n = 33) 20 13 
TOTAL 52 21 
"No significant difference in survival noted among the three 
groups, whether compared as shown in the table or with groups 6 to 
24 mo and >24 mo combined into a single group and compared to 
the <6 mo group. 
alive in April 1989 after OLT for alcoholic liver dis-
ease. Survival at 1 yr (Fig. 3), as calculated by the 
actuarial survival method, was 74%, a figure similar 
to that for the age· and sex· matched control patients 
receiving transplants for nonalcohol·induced hepato· 
cellular liver diseases at this institution. Median sur· 
vival time at the time of this survey was 18 rno for the 
alcoholic patients and 16 mo for the nonalcoholic pa-
tients, a difference that was not significant. 
Causes of Death. Of the 21 individuals who died as 
a result of liver transplantation, 6 (29%) died intra· 
operatively, 7 (33%) died in the immediate postopera· 
tive period and 8 (38%) died 3 or more mo after trans· 
plantation. Four of these died of sepsis and only two 
died of rejection (Table 3). Thus the most frequent cause 
of death was sepsis (9 of 21), with intraoperative deaths 
(6 of 21) being second. followed by rejection (2 of 21) 
and a variety of other causes (4 of 21) (Table 3). Most 
of the individuals (73%) who died after OLT were 
Child's class C. 
Recidivism. Of the 52 surviving recipients, only 6 
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FIG. 2. Age and sex distribution of persons receiving transplants for alcoholic liver disease at the University of Pittsburgh during period 
of study. 
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FIG. 3. Kaplan·Meier survival plots for 73 persons transplanted between July 1982 and April 1988 for alcoholic liver disease compared 
with survival of 73 individuals with nonalcoholic liver disease matched for age, sex and time of transplantation. 
(11.5%) have resumed alcohol consumption (Table 4l. 
Four drink socially, and a fifth. who began drinking 4 
mo after transplantation is consuming alcohol in mod-
erate amounts (three or fewer drinks per week). This 
individual. at the time of this survey, was selling lot-
tery tickets in a bar. The sixth individual has recently 
reduced his alcohol intake from moderate to social 
amounts after his physician warned him of test results 
indicating possible alcohol-induced liver injury. 
Only two discrepancies were noted, and in each case 
the physician felt that the recipient was drinking but 
both patient and spouse denied any alcohol consump-
tion was taking place (Table 5). The rate of recidivism 
was 43% in individuals who stopped drinking for less 
than 6 mo before OLT as compared with 6.7% for in-
dividuals who stopped drinking for more than 6 
months; this difference is statistically significant 
(p < 0.05). Of the four who died after discharge from 
the hospital one had resumed alcohol consumption and 
eventually died of allograft rejection; the rejection was 
at least in part a result of his noncompliance with im-
munosuppression and his recurrent alcohol abuse. 
Employment Status. Before their transplants. the 73 
patients had been unemployed for periods ranging from 
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TABLE 3. Cause of death after OLT for alcoholic liver disease 
Patient dead <3 mo after Patient dead >3 mo after 
transplantation (n = 8) Total transplantation (n = 13) 
Intraoperative death 
Cardiac arrest 3 
Bleeding !! 
TOTAL 6 
Postoperative death 
Sepsis 5 
Rejection 0 
Pulmonary embolism 0 
Intracranial hemorrhage 1 
Gastrointestinal bleeding 1 
TOTAL 7 
"NA = not applicable. 
TABLE 4. Alcohol consumption after liver transplantation 
Surviving patients 
Not drinking 
Drinking 
Social drinking 
Moderate drinking 
Excessive drinking 
Alcoholics 
52 
46 (88.5%) 
6 (11.5%) 
4 
2 
o 
Nonalcoholics 
49 
39 (79.6%) 
10 (20.4%) 
9 
1 
o 
TABLE 5. Agreement between patients, spouses and 
physicians on alcohol consumption 
Patients Spouses Physicians 
None 48 48 46 
Social 3 3 4 
Moderate 1 1 2 
Excessive 0 0 0 
several months to several years. Thirteen of the 52 sur-
vivors (25%) at time of follow-up were currently work-
ing full-time, 10 were working part-time <19%) and 5 
were self-employed (9.6%). Eleven were homemakers 
(21%), and 11 were unable to work (21%), Nine of the 
11 who claimed to be homemakers are women. The 
remaining two patients are willing to work but have 
not been able to find employment (Table 6), Twenty-
two of these 28 employed patients required at least 6 
mo of recuperation after their transplant operation be-
fore they could return to work. The percentage of work-
ing transplant survivors is no different from that seen 
in patients transplanted for diseases other than alco-
holism. 
Marital Status. Forty-five of the 52 surviving patients 
(86.5%) are married, 3 are divorced (5.7%), 3 are single 
(5.7%) and 1 is widowed <1.9%) (Table 7). It is notable 
that the alcoholic popUlation had a trend toward a 
higher percentage of married patients. There was no 
significant change in the marital status after aLT. 
Current Liver Enzyme Levels. The most recent ami-
NAG 3 
NA ~ 
6 
4 9 
2 2 
1 
1 2 
0 1 
8 15 
TABLE 6. Working status after OLT 
Working status Alcoholics Nonalcoholics 
Full time 13 14 
Part time 10 6 
Self-employed 5 2 
Housework 11 11 
Unable to work 11 14 
Willing to work, but 2 2 
unable to find job 
TOTAL 52 49 
notransferase levels (AST and ALT) obtained for each 
of the 52 surviving recipients transplanted for alcoholic 
liver disease are shown in Table 8. At the time of the 
survey, 36 transplanted patients had normal enzymes 
and 16 individuals had minor elevations of their serum 
aminotransferase levels. Only one individual had an 
ASTI ALT ratio greater than 2, suggesting alcoholic 
liver disease. This patient was known to and admitted 
to be drinking alcohol in moderate amounts. 
DISCUSSION 
In June 1983 the National Institutes of Health con-
vened a consensus development panel to develop guide-
lines for liver transplantation (6). In the section related 
to alcoholic liver disease, the panel attributed at least 
50% of the cases of cirrhosis in the United States to 
alcohol abuse and named alcoholism as the leading 
cause of hepatic morbidity and mortality in this coun-
try. Importantly, they did not state that alcoholics 
should be excluded from liver transplantation. In fact, 
they suggested quite the opposite: that liver trans-
plantation might be considered for patients in whom 
evidence of progressive liver failure has developed de-
spite available current medical treatment and absti-
nence from alcohol. Relatively few patients with alco-
holic liver disease have been transplanted, and an in-
crease in the number of chronic alcoholics being 
transplanted has not been seen, despite the increase in 
the number of transplant centers (5), 
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It is generally held that clinically advanced alcoholic 
liver disease carries a 5-yr survival rate of only 
50% (7), a prognosis worsened by the presence of as-
cites, portal hypertension, bleeding varices, hepatic en-
cephalopathy and hepatorenal syndrome. Before the 
development of OLT, no specific therapy for alcoholic 
liver disease other than the cessation of alcohol intake 
existed. This still remains the "ideal" therapy, but even 
alcohol abstinence may not allow survival in patients 
with far advanced disease. It has been shown that once· 
a certain level of hepatic damage has been reached, 
abstinence has no impact on survival (8,9). In such 
cases, liver transplantation is the only option for long-
term survival. 
The major argument against the widespread appli-
cation ofliver transplantation for alcoholic pati~nts has 
been a possible high rate of recidivism that would pre-
vent long-term survival and lead to redevelopment of 
the original liver disease in the allograft. Another ar-
gument has been that alcoholic patients, because they 
often have accompanying multiorgan disease, have 
only a poor chance for a successful outcome and a return 
to employment. Thus the major factors determining the 
candidacy of patients with alcohol-induced Ii ver disease 
for OLT have been related to aspects other than med-
ical issues. 
Most liver transplantation centers have set an ar-
bitrary period of abstinence, usually as a requirement 
before an alcoholic patient can be a candidate for trans-
plantation. Although abstinence is clearly of value in 
arresting alcoholic liver disease that is not end-stage, 
the benefit of alcohol abstinence before transplantation 
is undocumented. Contrary to the logical expectation 
that abstinence before transplantation would improve 
outcome, this study does not demonstrate a statistically 
significant difference between the survival of trans-
plant recipients who abstained from alcohol for at least 
6 mo before the transplantation and those who did not 
(Table 2l. It is interesting to note, however, that alcohol 
consumption in the immediate pretransplantation pe-
riod did predict postoperative recidivism. 
This study also clearly demonstrates that the recid-
ivism rate for alcoholism after OLT is rather low. The 
reason is unclear, but the trauma of a progressive de-
cline in health before transplantation, followed by the 
drama of facing an operation of the magnitude of OLT 
may have provided the motivation required for sus-
tained sobriety (10). Adequate social, family and psy-
chiatric support systems have no doubt substantially 
helped most of these survivors avoid an alcohol abuse 
relapse. 
Liver transplantation results in this series confirm 
the foresight of the consensus panel and show that al-
coholic patients with advanced liver disease can be 
transplanted successfully with a reasonable expecta-
tion of subsequent abstinence. employability and qual-
ity of life. These data also show that the 1-yr survival 
rate for individuals transplanted for alcoholic liver dis-
ease (74%) does not differ from that of persons receiving 
transplants for other hepatocellular diseases. In fact. 
TABLE 7. Marital status of liver transplant recipients 
Married Divorced Single Widow/er 
Alcoholic liver 45 3 3 
disease (n = 52) 
Nonalcoholic liver 31 7 9 2 
disease In = 49) 
TABLE 8. Serum AST and ALT levels of the surviving 
individuals at the last follow-up 
Alcoholics Nonalcoholics 
(n = 52) (n = 49) 
AST ALT AST ALT 
Normal 36 36 27 20 
<2 times upper limit of normal 9 7 12 13 
>2 times upper limit normal 7 9 10 16 
the survival rate is better than that reported for those 
receiving transplants for liver disease caused by 
chronic hepatitis B infection, HCC or cholangiocarci-
noma (11). Most importantly, most of these patients 
have been successfully rehabilitated and are able to go 
back to work or work in the home, and their quality of 
life appears to be equivalent to that of their nonalco-
holic counterparts. 
Many chronic alcoholic patients die of end-stage al-
coholic liver disease or one of its complications such as 
bleeding varices or the hepatorenal syndrome (12). 
These deaths may be preventable now that the therapy 
of liver transplantation is available for at least some 
of these patients. It should be noted, too, that most 
physicians provide therapy to smokers, the obese, drug 
addicts or persons with venereal disease, and porta-
caval shunting or sclerotherapy treatment is provided 
to patients with cirrhosis who do not claim they will 
lead a life of abstinence (13), Available data suggest 
that the recidivism rates for smoking, drug addiction 
and obesity may be equal to, or greater than, those for 
alcoholism. but these relapse rates are not used to deny 
medical care to those who require it. Unwillingness to 
offer liver transplantation to individuals with alcoholic 
liver disease because of a failure to demonstrate long-
term abstinence, particularly in view of the great risk 
for death without OLT, appears difficult to defend. 
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